Reta (Retatrutide) plotter

Investigational triple agonist. Published half-life is about 6 days; weekly overlap similar to tirzepatide.

t½ 6dTmax 2d100% parentGLP-1mg

Also called Retatrutide.

Phase 2 PK: retatrutide terminal half-life ~6 days.

Your cycle

Dose, ester, and frequency. The chart is remaining active amount, not serum concentration. To step a dose up, add another row of the same compound with a later start day.

Compound 1

t½ 6dTmax 2d100% parent

Dose (mg)

Frequency

Start day

Duration (weeks)

Per-compound linesTotal line

Peaks, troughs, and half-life

Estimated remaining active mg. Washout continues after the last dose. Mixed IU and mg protocols are not summed.

Retatrutide

Peak

3.60 mg

Trough

2.02 mg

Swing

44%

~Steady state

30d

~Washout

32d

Saved locally

Stored in localStorage on this device. Reload a saved protocol from this list.

No saved protocols in this browser yet.